Pay in 4 interest-free payments of $5.97 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
A scientific review published in the National Library of Medicine in 2022 found that nose-to-brain delivery of therapeutic peptides is a non-invasive and fast-acting method that can effectively bypass the blood-brain barrier while minimizing systemic exposure
This is the use case where AOD-9604 has the most appeal but potentially the least clinical data to support it
Naturally occurring amino acids have an L chiral configuration, while the DRI peptides appear to be composed of D chiral amino acids
Choose the vial only if you want the standard lyophilised format
US$ 21.61
US$ 25.55
US$ 28.36
US$ 20.55
US$ 21.16
